Variant report
Variant | esv2643023 |
---|---|
Chromosome Location | chr16:72752833-72754522 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:72750286..72753013-chr16:72758425..72760232,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9933493 | chr16:72752859-72752860 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs116427558 | chr16:72752873-72752874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs377320653 | chr16:72752874-72752875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576093447 | chr16:72752882-72752883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183812769 | chr16:72752905-72752906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536753349 | chr16:72752913-72752914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554770163 | chr16:72752924-72752925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139645407 | chr16:72752932-72752933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113153646 | chr16:72752983-72752984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12921751 | chr16:72753028-72753029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572973242 | chr16:72753041-72753042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs370283710 | chr16:72753073-72753074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs76768639 | chr16:72753075-72753076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186705181 | chr16:72753085-72753086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543803352 | chr16:72753243-72753244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552006295 | chr16:72753298-72753299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7195014 | chr16:72753299-72753300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368874863 | chr16:72753303-72753304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs375414683 | chr16:72753395-72753396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113894268 | chr16:72753593-72753594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs111566580 | chr16:72753594-72753595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112265932 | chr16:72753595-72753596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562147931 | chr16:72753666-72753667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545015001 | chr16:72753689-72753690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529703904 | chr16:72753722-72753723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541543713 | chr16:72753740-72753741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192453261 | chr16:72753774-72753775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377535535 | chr16:72753789-72753790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547210889 | chr16:72753820-72753821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571842168 | chr16:72753828-72753829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543990688 | chr16:72753832-72753833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550953888 | chr16:72753851-72753852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572071465 | chr16:72753911-72753912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536714687 | chr16:72753920-72753921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548370041 | chr16:72753938-72753939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184362982 | chr16:72753967-72753968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370897679 | chr16:72753969-72753970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375080991 | chr16:72753994-72753995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13332581 | chr16:72754019-72754020 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs558763769 | chr16:72754029-72754030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs145304074 | chr16:72754107-72754108 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190566766 | chr16:72754127-72754128 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs193242131 | chr16:72754147-72754148 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368718300 | chr16:72754157-72754158 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555709160 | chr16:72754176-72754177 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184560839 | chr16:72754189-72754190 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147633700 | chr16:72754190-72754191 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559980910 | chr16:72754228-72754229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188875236 | chr16:72754317-72754318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs541702718 | chr16:72754337-72754338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chordoma | 18071362 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Infiltrating lobular breast cancer | 19191266 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ependymoma | 18628472 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:72746400-72760800 | Weak transcription | Primary hematopoietic stem cells | blood |
2 | chr16:72746600-72755400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr16:72747800-72757600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
4 | chr16:72749400-72756200 | Weak transcription | Ovary | ovary |
5 | chr16:72750000-72755400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr16:72750000-72755800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr16:72750400-72755600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr16:72750600-72757200 | Weak transcription | Dnd41 | blood |
9 | chr16:72750600-72763200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr16:72750800-72753400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr16:72751800-72755600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr16:72754000-72754200 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr16:72754000-72754200 | Enhancers | H9 Cell Line | embryonic stem cell |
14 | chr16:72754000-72754200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr16:72754000-72754200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr16:72754000-72754200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
17 | chr16:72754200-72755400 | Weak transcription | H1 Cell Line | embryonic stem cell |
18 | chr16:72754200-72755400 | Weak transcription | H9 Cell Line | embryonic stem cell |
19 | chr16:72754200-72759000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
20 | chr16:72754400-72755400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
21 | chr16:72754400-72755400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |